LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Banerji, A.
Hao, J.
Yu, M.
Bernstein, J.
Johnston, D.
Riedl, M.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 125卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P150
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [31] ABP 501 BIOSMILAR TO ADALIMUMAB: FINAL SAFETY, IMMUNOGENICITY, AND EFFICACY RESULTS FROM AN OPEN-LABEL EXTENSION STUDY
    Cohen, S.
    Pablos, J. L.
    Wang, H.
    Mueller, G. A.
    Kivitz, A.
    Matsumoto, A.
    Krishnan, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 834 - 835
  • [32] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
  • [33] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [34] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
    Brunner, Hermine I.
    Akikusa, Jonathan D.
    Al-Abadi, Eslam
    Bohnsack, John F.
    Boteanu, Alina Lucica
    Chedeville, Gaelle
    Cuttica, Ruben
    De La Pena, Wendy
    Jung, Lawrence
    Kasapcopur, Ozgur
    Kobusinska, Katarzyna
    Schulert, Grant S.
    Neiva, Claudia
    Rivas-Chacon, Rafael
    Rizo Rodriguez, Juan Cruz
    Vazquez-Del Mercado, Monica
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Wouters, Carine
    Posner, Holly
    Wouters, Ann
    Chang, Cheng
    White, Claire
    Kanik, Keith
    Liu, Shixue
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11) : 1561 - 1571
  • [35] Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study
    Chatham, W. Winn
    Furie, Richard
    Saxena, Amit
    Brohawn, Philip
    Schwetje, Erik
    Abreu, Gabriel
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 837 - 847
  • [36] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [37] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
    Brunner, Hermine I.
    Akikusa, Jonathan D.
    Al-Abadi, Eslam
    Bohnsack, John F.
    Boteanu, Alina Lucica
    Chedeville, Gaelle
    Cuttica, Ruben
    De La Pena, Wendy
    Jung, Lawrence
    Kasapcopur, Ozgur
    Kobusinska, Katarzyna
    Schulert, Grant S.
    Neiva, Claudia
    Rivas-Chacon, Rafael
    Rizo Rodriguez, Juan Cruz
    Vazquez-Del Mercado, Monica
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Wouters, Carine
    Posner, Holly
    Wouters, Ann
    Chang, Cheng
    White, Claire
    Kanik, Keith
    Liu, Shixue
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11) : 1561 - 1571
  • [38] Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study
    Kuter, David J.
    Bussel, James B.
    Newland, Adrian
    Wasser, Jeffrey S.
    Lyons, Roger M.
    George, James N.
    Macik, Gail
    Nie, Kun
    Jun, Susie
    BLOOD, 2010, 116 (21) : 36 - 37
  • [39] Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study
    Anderson, K.
    Stamler, D.
    Davis, M.
    Factor, S.
    Hauser, R.
    Isojarvi, J.
    Jarskog, L.
    Jimenez-Shahed, J.
    Kumar, R.
    Ochudlo, S.
    Ondo, W.
    Fernandez, H.
    MOVEMENT DISORDERS, 2017, 32
  • [40] Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
    Barratt, Jonathan
    Barbour, Sean
    Brenner, Robert
    Cooper, Kerry
    Wei, Xuelian
    Eren, Necmi
    Floege, Juergen
    Jha, Vivekanand
    Kim, Sung Gyun
    Maes, Bart
    Phoon, Richard K. S.
    Singh, Harmeet
    Tesar, Vladimir
    Lafayette, Richard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024,
12345